Back to all companies

Olio Labs

Summer 2023Active

Combination therapeutics for the world's toughest diseases

Olio Labs

Summer 2023Active

Combination therapeutics for the world's toughest diseases

Company details

Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.

Location

Remote

Founded

Unknown

YC profile oliolabs.co

Founders

DT
David Tingley
Founder
X / Twitter LinkedIn
TR
Tom Roseberry
Founder
X / Twitter LinkedIn

Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.

Location

Remote

Founded

Unknown

YC profile oliolabs.co

Founders

DT
David Tingley
Founder
X / Twitter LinkedIn
TR
Tom Roseberry
Founder
X / Twitter LinkedIn

Request the Olio Labs report.

Olio Labs has no report yet. Sign in with your email to request one.

Sign in to request